4.7 Review

Wld(S), Nmnats and axon degeneration-progress in the past two decades

Journal

PROTEIN & CELL
Volume 1, Issue 3, Pages 237-245

Publisher

SPRINGEROPEN
DOI: 10.1007/s13238-010-0021-2

Keywords

axon degeneration; Wallerian degeneration; Wld(S); NAD; neurodegenerative diseases

Categories

Funding

  1. National Natural Science Foundation of China [30570558, 30825009]
  2. National Basic Research Program of China (973 Program) [2009CB918403, 2007CB914501]
  3. Shanghai Rising-Star Program from Science and Technology Commission of Shanghai Municipality [08QH1402600]

Ask authors/readers for more resources

A chimeric protein called Wallerian degeneration slow (Wld(S)) was first discovered in a spontaneous mutant strain of mice that exhibited delayed Wallerian degeneration. This provides a useful tool in elucidating the mechanisms of axon degeneration. Over-expression of Wld(S) attenuates the axon degeneration that is associated with several neurodegenerative disease models, suggesting a new logic for developing a potential protective strategy. At molecular level, although Wld(S) is a fusion protein, the nicotinamide mononucleotide adenylyl transferase 1 (Nmnat1) is required and sufficient for the protective effects of Wld(S), indicating a critical role of NAD biosynthesis and perhaps energy metabolism in axon degeneration. These findings challenge the proposed model in which axon degeneration is operated by an active programmed process and thus may have important implication in understanding the mechanisms of neurodegeneration. In this review, we will summarize these recent findings and discuss their relevance to the mechanisms of axon degeneration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available